The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Installed Building Products Inc
SWB:2IL
|
US |
|
A
|
Afi Properties Ltd
TASE:AFPR
|
IL |
|
I
|
ICD Co Ltd
KOSDAQ:040910
|
KR |
|
O
|
Observe Medical ASA
OSE:OBSRV
|
NO |
|
Nephros Inc
NASDAQ:NEPH
|
US |
|
Iberdrola SA
OTC:IBDRY
|
ES |
|
MNC Asia Holding Tbk PT
IDX:BHIT
|
ID |
|
M
|
MONY Group PLC
SWB:39M
|
UK |
|
Gecina SA
F:GI6A
|
FR |
|
Pepkor Holdings Ltd
OTC:PPKRF
|
ZA |
|
B
|
Blu Label Unlimited Group Ltd
XMUN:5TP
|
ZA |
|
F
|
Frontdoor Inc
F:3I5
|
US |
|
L
|
Lindab International AB
F:L5E
|
SE |
|
H
|
Haoxi Health Technology Ltd
NASDAQ:HAO
|
CN |
|
M
|
Macquarie Group Ltd
F:4M4
|
AU |
|
S
|
SM Entertainment Co Ltd
KOSDAQ:041510
|
KR |
|
T
|
Tungray Technologies Inc
NASDAQ:TRSG
|
SG |
|
B
|
BWP Trust
OTC:BUNNF
|
AU |
|
Geberit AG
F:GBRF
|
CH |
|
N
|
National Australia Bank Ltd
SWB:NAL
|
AU |
|
Caltagirone Editore SpA
MIL:CED
|
IT |
|
Aminex PLC
LSE:AEX
|
UK |
|
C
|
Clearmind Medicine Inc
NASDAQ:CMND
|
CA |
|
N
|
Northrop Grumman Corp
LSE:0K92
|
US |
Installed Building Products Inc (2IL)’s 12-month stock price forecast through September 2027 has a consensus target of €193.77, implying 12% upside. The forecast is based on price targets from 13 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
2IL is 193.77 EUR with a low forecast of 142.79 EUR and a high forecast of 238.44 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 3 years is 3%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 22%. The projected CAGR for the next 3 years is 3%.
The compound annual growth rate for Operating Income over the next 3 years is 4%.
The compound annual growth rate for Pre-Tax Income over the next 3 years is 6%.
The compound annual growth rate for Net Income over the next 3 years is 7%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more